These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1685293)

  • 21. An intracellular study of the action of NAN-190 on neurons in the dorsal raphe nucleus of the rat.
    Hodgkiss JP; Dawson IM; Kelly JS
    Brain Res; 1992 Mar; 576(1):157-61. PubMed ID: 1387576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buspirone, 8-OH-DPAT and ipsapirone: effects on hippocampal cerebellar and sciatic fiber excitability.
    Hiner BC; Mauk MD; Peroutka SJ; Kocsis JD
    Brain Res; 1988 Sep; 461(1):1-9. PubMed ID: 2906267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?
    Jolas T; Schreiber R; Laporte AM; Chastanet M; De Vry J; Glaser T; Adrien J; Hamon M
    J Pharmacol Exp Ther; 1995 Feb; 272(2):920-9. PubMed ID: 7853210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential use of drugs modulating 5HT activity in the treatment of anxiety.
    Gardner CR
    Gen Pharmacol; 1988; 19(3):347-56. PubMed ID: 2901381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of 5-HT1A selective anxiolytics on lordosis behavior: interactions with progesterone.
    Mendelson SD; Gorzalka BB
    Eur J Pharmacol; 1986 Dec; 132(2-3):323-6. PubMed ID: 2880737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor.
    Sinton CM; Fallon SL
    Eur J Pharmacol; 1988 Nov; 157(2-3):173-81. PubMed ID: 2906291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist.
    Caicoya AG; Beneytez ME; Delgado M; Manzanares J; López-Rodríguez ML; Benhamu B; Morcillo MJ; Pozo MA; Rubia FJ; Fuentes JA
    Pharmacology; 2001 May; 62(4):234-42. PubMed ID: 11360001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin-glutamate interaction in rat cerebellum: involvement of 5-hydroxytryptamine receptor subtypes.
    Maura G; Bonanno G; Pittaluga A; Ulivi M; Raiteri M
    Ann Ist Super Sanita; 1988; 24(3):389-95. PubMed ID: 2903707
    [No Abstract]   [Full Text] [Related]  

  • 29. Behavioral studies with anxiolytic drugs. IV. Serotonergic involvement in the effects of buspirone on punished behavior of pigeons.
    Witkin JM; Mansbach RS; Barrett JE; Bolger GT; Skolnick P; Weissman B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):970-7. PubMed ID: 2891840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CGS 18102A, a benzopyranopyridine anxiolytic with 5-HT1 agonist and 5-HT2 antagonist properties.
    Sills MA; Bennett DA; Lovell RA; Liebman JM; Wood PL; Glaeser BS; Williams M; Hutchison AJ
    Prog Clin Biol Res; 1990; 361():469-75. PubMed ID: 1981265
    [No Abstract]   [Full Text] [Related]  

  • 31. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
    Bagdy G; Kalogeras KT
    Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The involvement of 5-hydroxytryptaminergic and dopaminergic mechanisms in the eating induced by buspirone, gepirone and ipsapirone.
    Fletcher PJ; Davies M
    Br J Pharmacol; 1990 Mar; 99(3):519-25. PubMed ID: 2139586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in anterior pituitary hormone levels after serotonin 1A receptor stimulation.
    Di Sciullo A; Bluet-Pajot MT; Mounier F; Oliver C; Schmidt B; Kordon C
    Endocrinology; 1990 Aug; 127(2):567-72. PubMed ID: 2164913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of serotoninergic drugs on stress-induced hyperthermia (SIH) in mice.
    Lecci A; Borsini F; Mancinelli A; D'Aranno V; Stasi MA; Volterra G; Meli A
    J Neural Transm Gen Sect; 1990; 82(3):219-30. PubMed ID: 1979003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pressor effects following microinjection of 5-HT1A receptor agonists into the raphe obscurus of the anaesthetized rat.
    Dreteler GH; Wouters W; Saxena PR; Ramage AG
    Br J Pharmacol; 1991 Feb; 102(2):317-22. PubMed ID: 1673069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of serotonin (5-HT1A and 5-HT2) agonists and antagonists on renin and corticosterone secretion.
    Lorens SA; Van de Kar LD
    Neuroendocrinology; 1987 Apr; 45(4):305-10. PubMed ID: 2952898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discriminative stimulus properties of the serotonergic compound eltoprazine.
    Ybema CE; Slangen JL; Olivier B; Mos J
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1045-51. PubMed ID: 1532031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
    Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M
    J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of azapirones on serotonin1A neurons of the dorsal raphe.
    Matheson GK; Pfeifer DM; Weiberg MB; Michel C
    Gen Pharmacol; 1994 Jul; 25(4):675-83. PubMed ID: 7958728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [An analysis of the hypothermic action of 8-hydroxy-2-(di-N-propylamino)tetralin, 1-(2-pyrimidinyl)piperazine and its derivatives].
    Komissarov IV; Dolzhenko AT; Obraztsova OG; Zin'kovskaia LIa
    Biull Eksp Biol Med; 1990 Mar; 109(3):275-7. PubMed ID: 2142007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.